These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34232570)

  • 1. High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion.
    Geyer PE; Arend FM; Doll S; Louiset ML; Virreira Winter S; Müller-Reif JB; Torun FM; Weigand M; Eichhorn P; Bruegel M; Strauss MT; Holdt LM; Mann M; Teupser D
    EMBO Mol Med; 2021 Aug; 13(8):e14167. PubMed ID: 34232570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.
    Sahin AT; Yurtseven A; Dadmand S; Ozcan G; Akarlar BA; Kucuk NEO; Senturk A; Ergonul O; Can F; Tuncbag N; Ozlu N
    Proteomics Clin Appl; 2023 Mar; 17(2):e2200070. PubMed ID: 36217943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology.
    Villar M; Urra JM; Rodríguez-Del-Río FJ; Artigas-Jerónimo S; Jiménez-Collados N; Ferreras-Colino E; Contreras M; de Mera IGF; Estrada-Peña A; Gortázar C; de la Fuente J
    Front Immunol; 2021; 12():730710. PubMed ID: 34566994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.
    Buchholtz ML; Arend FM; Eichhorn P; Weigand M; Kleinhempel A; Häusler K; Bruegel M; Holdt LM; Teupser D
    PLoS One; 2021; 16(5):e0251587. PubMed ID: 33984048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays.
    Yun S; Ryu JH; Jang JH; Bae H; Yoo SH; Choi AR; Jo SJ; Lim J; Lee J; Ryu H; Cho SY; Lee DG; Lee J; Kim SC; Park YJ; Lee H; Oh EJ
    Ann Lab Med; 2021 Nov; 41(6):577-587. PubMed ID: 34108285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative proteomics and metabolomics study reveal enhanced immune responses by COVID-19 vaccine booster shot against Omicron SARS-CoV-2 infection.
    Wang B; Yang W; Tong Y; Sun M; Quan S; Zhu J; Zhang Q; Qin Z; Ni Y; Zhao Y; Wang K; Zhang C; Zhang Y; Wang Z; Song Z; Liu H; Fang H; Kong Z; Ding C; Guo W
    J Med Virol; 2023 Nov; 95(11):e29219. PubMed ID: 37966997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal and proteome-wide analyses of antibodies in COVID-19 patients reveal features of the humoral immune response to SARS-CoV-2.
    Wang J; Yang Y; Liang T; Yang N; Li T; Zheng C; Ning N; Luo D; Yang X; He Z; Yang G; Li B; Gao J; Yu W; Gong S; Huang Y; Li J; Wang H; Zhang H; Zhang T; Li P; Li Y; Dai J; Zhang X; Li B; Yu X; Wang H
    J Adv Res; 2022 Mar; 37():209-219. PubMed ID: 35475278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Proteome Signatures of Anti-SARS-CoV-2 Vaccinated Healthcare Workers in Greece Associated with Their Prior Infection Status.
    Stamoula E; Sarantidi E; Dimakopoulos V; Ainatzoglou A; Dardalas I; Papazisis G; Kontopoulou K; Anagnostopoulos AK
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients.
    Bondt A; Hoek M; Dingess K; Tamara S; de Graaf B; Peng W; den Boer MA; Damen M; Zwart C; Barendregt A; van Rijswijck DMH; Schulte D; Grobben M; Tejjani K; van Rijswijk J; Völlmy F; Snijder J; Fortini F; Papi A; Volta CA; Campo G; Contoli M; van Gils MJ; Spadaro S; Rizzo P; Heck AJR
    Mol Cell Proteomics; 2024 Jan; 23(1):100690. PubMed ID: 38065436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients.
    Mun DG; Vanderboom PM; Madugundu AK; Garapati K; Chavan S; Peterson JA; Saraswat M; Pandey A
    J Proteome Res; 2021 Aug; 20(8):4165-4175. PubMed ID: 34292740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.
    Captur G; Moon JC; Topriceanu CC; Joy G; Swadling L; Hallqvist J; Doykov I; Patel N; Spiewak J; Baldwin T; Hamblin M; Menacho K; Fontana M; Treibel TA; Manisty C; O'Brien B; Gibbons JM; Pade C; Brooks T; Altmann DM; Boyton RJ; McKnight Á; Maini MK; Noursadeghi M; Mills K; Heywood WE;
    EBioMedicine; 2022 Nov; 85():104293. PubMed ID: 36182629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual COVID-19 disease trajectories revealed by plasma proteomics.
    Memon D; Barrio-Hernandez I; Beltrao P
    EMBO Mol Med; 2021 Aug; 13(8):e14532. PubMed ID: 34260159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system.
    Ayass MA; Cao W; Zhang J; Dai J; Zhu K; Tripathi T; Griko N; Pashkov V; Abi-Mosleh L
    PLoS One; 2022; 17(9):e0274228. PubMed ID: 36094909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies.
    Wu S; Xu Y; Zhang J; Ran X; Jia X; Wang J; Sun L; Yang H; Li Y; Fu B; Huang C; Liao P; Sun W
    Front Immunol; 2022; 13():893943. PubMed ID: 35958562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Seroconversion Rate Against Severe Acute Respiratory Syndrome Coronavirus 2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.
    Ruan W; Nguyen H; Wyatt A; Ihekweazu F; Vartabedian BS; Karam L; Walsh S; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):363-366. PubMed ID: 34173793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing.
    Zecha J; Lee CY; Bayer FP; Meng C; Grass V; Zerweck J; Schnatbaum K; Michler T; Pichlmair A; Ludwig C; Kuster B
    Mol Cell Proteomics; 2020 Sep; 19(9):1503-1522. PubMed ID: 32591346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2.
    Stocking C; de Miguel L; Suteu G; Dressel A; Soricelli A; Roskos M; Valor S; Mutschmann C; März W
    Diagn Microbiol Infect Dis; 2022 Feb; 102(2):115587. PubMed ID: 34826767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection.
    Urbiola-Salvador V; Lima de Souza S; Grešner P; Qureshi T; Chen Z
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.